Puneeta Tandon

University of Alberta
Country flagCanada

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background: Nutrition and exercise are the mainstay of therapy for the prevention and treatment of frailty in cirrhosis. This pilot study assessed feasibility of the online delivery of an app-based semi-supervised nutrition and exercise intervention in this population. Methods: The 11-week pilot recruited adults with cirrhosis who owned internet-connected devices. Patients were encouraged to participate in exercise sessions 3× per week including a combination of online group exercise (weekly) and home-based follow-along exercise (biweekly). They also participated in group nutrition classes (five sessions) and one-to-one exercise and nutrition check-ins delivered through the app. Primary outcome measures pertained to program feasibility: recruitment, retention, adherence, and satisfaction. Exploratory measures included physical performance (liver frailty index [LFI], 6-minute walk test [6MWT]), health behaviour domains, and quality of life. Results: Twenty three patients completed baseline measures. Of these, 18 (72%) completed end of study measures (mean MELD-Na, 9.2; female, 44.4%). Over 70% of participants fulfilled 75% or more of the feasibility criteria. Satisfaction with the program was high (mean, 89%). Exercise program modifications were required for 17 patients to accommodate health events or abilities. Exploratory evaluation showed improvement in the LFI and the 6MWT by −0.58-units (95% CI: −0.91 to −0.25) and 46.0 m (95% CI: 22.7–69.3) respectively without changes in quality of life or health behaviour domains. Conclusions: Outcomes demonstrate feasibility of the app-based delivery of programming with promising exploratory impact on efficacy for physical performance. Findings can guide the design of a large-scale app-based randomized controlled trials in cirrhosis.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Hugo E. Vargas

Consultant/Professor of Medicine

Mayo Clinic Arizona

UNITED STATES
View details

Vijay Daniels

University of Alberta

CANADA
View details

judith Spiers

Associate Professor

University of Alberta

CANADA
View details

Leroy Thacker

Associate Professor

Virginia Commonwealth University

UNITED STATES
View details

Stéphanie Bernard

Assistant professor

Laval University

CANADA
View details

Florence Wong

Professor

University of Toronto

CANADA
View details

John C. Spence

Professor

University of Alberta

CANADA
View details

Robert G. Martindale

-

UNITED STATES
View details

Ruben Hernaez

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Chelsia Gillis

-

CANADA
View details

Jennifer Lai

University of California, San Francisco

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.